Breast Cancer News

Health care professionals who experienced recent weight loss had a significantly higher risk for a cancer diagnosis during the subsequent 12 months, results of a prospective cohort analysis revealed.

SAN ANTONIO — Tinengotinib exhibited activity among heavily pretreated patients with hormone receptor-positive, HER2-negative breast cancer or those with triple-negative disease, according to study results.

Preliminary results of a phase 1 trial for a novel vaccine that could eventually prevent triple-negative breast cancer exceeded expectations, based on data presented at San Antonio Breast Cancer Symposium.

Breast cancer screening and treatments in 2019 were both associated with more than 50% reduction in U.S. breast cancer mortality compared with interventions utilized over 4 decades ago, according to analysis results published in JAMA.

Patients with cancer enrolled in high-deductible health-care plans paid, on average, nearly 70% more in out-of-pocket medical expenses annually than those in low-deductible plans, according to a study in JAMA Oncology.

Cancer mortality in the U.S. is projected to decline again in 2024, but the number of new diagnoses should top 2 million for the first time, an annual report from the American Cancer Society revealed.

Homeless veterans with lung or colorectal cancers had higher mortality rates than housed veterans, study data published in JAMA Network Open showed.

This year’s San Antonio Breast Cancer Symposium featured several high-impact abstracts.

Women aged 35 years or younger with breast cancer had a higher risk for developing contralateral breast cancer compared with women older than 35 years, according to cohort study results published in JAMA Network Open.

All women with breast cancer should undergo genetic testing for BRCA1 and BRCA2 mutations, according to study findings presented at San Antonio Breast Cancer Symposium.